Kevin S. Sr. Boyle - Aug 30, 2022 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Chief Executive Officer, Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Aug 30, 2022
Transactions value $
-$45,188
Form type
4
Date filed
9/1/2022, 04:30 PM
Previous filing
Apr 1, 2022
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Tax liability -$45.2K -18.8K -2.12% $2.41* 866K Aug 30, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligations in connection with the vesting of shares of restricted stock previously granted to the Reporting Person.